For the quarter ending 2025-09-30, CLSD has $11,641K in assets. $65,591K in debts. $6,801K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 6,801 | 9,376 | ||
| Accounts receivable | 266 | 816 | ||
| Prepaid expenses | 1,187 | 1,580 | ||
| Other current assets | 0 | 13 | ||
| Total current assets | 8,254 | 11,785 | ||
| Total property and equipment | 4,380 | - | ||
| Less accumulated depreciation | 1,399 | - | ||
| Property and equipment, net | 2,981 | 3,065 | ||
| Operating lease right-of-use asset | 376 | 452 | ||
| Other assets | 30 | 30 | ||
| Total assets | 11,641 | 15,332 | ||
| Accounts payable (includes 491 to a related party as of december 31, 2024) | 796 | 1,129 | ||
| Accrued liabilities (includes 304 to a related party as of december 31, 2024) | 1,590 | 1,537 | ||
| Current portion of operating lease liabilities | 384 | 381 | ||
| Total current liabilities | 2,770 | 3,047 | ||
| Liability related to the sales of future royalties, net | 61,167 | 55,702 | ||
| Warrant liabilities | 1,192 | 4,765 | ||
| Operating lease liabilities | 62 | 152 | ||
| Other non-current liabilities | 400 | 400 | ||
| Total liabilities | 65,591 | 64,066 | ||
| Common stock, 0.001 par value 26,666,666 and 13,333,333 shares authorized at september 30, 2025 and december 31, 2024, respectively 5,233,981 and 5,105,216 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively | 78 | 78 | ||
| Additional paid-in capital | 319,937 | 319,181 | ||
| Accumulated deficit | -373,965 | -367,993 | ||
| Total stockholders deficit | -53,950 | -48,734 | ||
| Total liabilities and stockholders deficit | 11,641 | 15,332 | ||
Clearside Biomedical, Inc. (CLSD)
Clearside Biomedical, Inc. (CLSD)